Abstract
Challenges with surgical treatment of glaucoma are numerous and frequent, especially with the more complicated forms such as neovascular or uveitic glaucoma. Surgeries often fail which have driven the search for using a surgical adjunct to improve the outcomes and longevity of glaucoma procedures, while lowering their complication rates. VEGF levels have been found to be elevated in patients with both primary open angle glaucoma and secondary glaucomas. The use of anti-VEGF agents is now being investigated in the treatment of all types of glaucoma. The information is early and limited, but what is known will be reviewed in this article. In considering anti-VEGF agents in the treatment of glaucoma, some evidence suggests that anti-VEGF agents may induce glaucoma by elevating intraocular pressure, which will also be reviewed.
Keywords: Antivascular endothelial growth factor, bevacizumab, bleb, glaucoma, intraocular pressure, mitomycin C, neovascular glaucoma, ranibizumab, trabeculectomy, glaucoma, surgery
Current Drug Therapy
Title:Anti-VEGF Treatment of Glaucoma
Volume: 7 Issue: 2
Author(s): Rick E. Bendel
Affiliation:
Keywords: Antivascular endothelial growth factor, bevacizumab, bleb, glaucoma, intraocular pressure, mitomycin C, neovascular glaucoma, ranibizumab, trabeculectomy, glaucoma, surgery
Abstract: Challenges with surgical treatment of glaucoma are numerous and frequent, especially with the more complicated forms such as neovascular or uveitic glaucoma. Surgeries often fail which have driven the search for using a surgical adjunct to improve the outcomes and longevity of glaucoma procedures, while lowering their complication rates. VEGF levels have been found to be elevated in patients with both primary open angle glaucoma and secondary glaucomas. The use of anti-VEGF agents is now being investigated in the treatment of all types of glaucoma. The information is early and limited, but what is known will be reviewed in this article. In considering anti-VEGF agents in the treatment of glaucoma, some evidence suggests that anti-VEGF agents may induce glaucoma by elevating intraocular pressure, which will also be reviewed.
Export Options
About this article
Cite this article as:
E. Bendel Rick, Anti-VEGF Treatment of Glaucoma, Current Drug Therapy 2012; 7 (2) . https://dx.doi.org/10.2174/157488512800675995
DOI https://dx.doi.org/10.2174/157488512800675995 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine
Current Pharmaceutical Design Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Current Vascular Pharmacology NADPH Oxidases in the Heart
Current Cardiology Reviews Development and Application of a Highly Selective Biomimetic Sensor for Detection of Captopril, an Important Ally in Hypertension Control
Combinatorial Chemistry & High Throughput Screening Editorial (Thematic Issue: Molecular Basis of Gastrointestinal Chemical Senses)
Current Pharmaceutical Design Life-Threatening Respiratory Syncytial Virus Disease in Children
Current Respiratory Medicine Reviews Expression and Function of Anti-Inflammatory Interleukins: The Other Side of the Vascular Response to Injury
Current Vascular Pharmacology Synthetic Methods for the Preparation of Triazepandiones and Review of their Applications
Current Organic Chemistry Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition Targets for Steroid Hormone Mediated Actions of Periodontal Pathogens, Cytokines and Therapeutic Agents Some Implications on Tissue Turnover in the Periodontium
Current Drug Targets Case Report: Severe Hematological, Muscle and Liver Toxicity Caused by Drugs and Artichoke Infusion Interaction in an Elderly Polymedicated Patient
Current Drug Safety Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition Editorial [Hot Topic Management of Perioperative Systemic Inflammation During Cardiopulmonary Bypass: We Need a Multimodal Approach (Guest Editor: David Faraoni)]
Recent Patents on Cardiovascular Drug Discovery Modifying Radiation Damage
Current Drug Targets Stroke Suggests Increased Risk of Dementia
Current Alzheimer Research Mobile Phone Based Health Care Technology
Recent Patents on Biomedical Engineering (Discontinued) Stem Cell Gene Therapy for Chronic Renal Failure
Current Gene Therapy Editorial (Hot Topic: Central Blood Pressure: Current Status and Future Perspective)
Current Hypertension Reviews Intra-Renal Hemodynamic Changes After Habitual Physical Activity in Patients with Chronic Kidney Disease
Current Pharmaceutical Design